-
13299-5A cell permeable inhibitor of PKC with IC<sub>50</sub> values reported to range from 0.10 to 0.
-
13334-1A potent, cell-permeable inhibitor of PKC isoforms (IC<sub>50</sub> = 5, 24, 14, 27, and 24 nM for PKC-&alpha, PKC-&betaI, PKC-&betaII, PKC-&gamma, and PKC-&epsilon, respectively).
-
13334-10A potent, cell-permeable inhibitor of PKC isoforms (IC<sub>50</sub> = 5, 24, 14, 27, and 24 nM for PKC-&alpha, PKC-&betaI, PKC-&betaII, PKC-&gamma, and PKC-&epsilon, respectively).
-
13334-5A potent, cell-permeable inhibitor of PKC isoforms (IC<sub>50</sub> = 5, 24, 14, 27, and 24 nM for PKC-&alpha, PKC-&betaI, PKC-&betaII, PKC-&gamma, and PKC-&epsilon, respectively).
-
13300-1A weak inhibitor of PKC demonstrating an IC<sub>50</sub> value >100 µM blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC<sub>50</sub> value of 8 µM.
-
13300-10A weak inhibitor of PKC demonstrating an IC<sub>50</sub> value >100 µM blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC<sub>50</sub> value of 8 µM.
-
13300-25A weak inhibitor of PKC demonstrating an IC<sub>50</sub> value >100 µM blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC<sub>50</sub> value of 8 µM.
-
13300-5A weak inhibitor of PKC demonstrating an IC<sub>50</sub> value >100 µM blocks the activation of mitogen-stimulated protein kinase p70s6k/p85s6k (S6K) in vivo with an IC<sub>50</sub> value of 8 µM.
-
13333-1A selective PKC inhibitor (IC<sub>50</sub> = 158 nM for rat brain PKC) that acts at the ATP binding site of PKC exhibits PKC isozyme specificity with preference for PKC&alpha over PKC&betaI, PKC&betaII, PKC&gamma, or PKC&epsilon
-
13333-10A selective PKC inhibitor (IC<sub>50</sub> = 158 nM for rat brain PKC) that acts at the ATP binding site of PKC exhibits PKC isozyme specificity with preference for PKC&alpha over PKC&betaI, PKC&betaII, PKC&gamma, or PKC&epsilon
-
13333-5A selective PKC inhibitor (IC<sub>50</sub> = 158 nM for rat brain PKC) that acts at the ATP binding site of PKC exhibits PKC isozyme specificity with preference for PKC&alpha over PKC&betaI, PKC&betaII, PKC&gamma, or PKC&epsilon
-
17511-1A cell-permeable, reversible, ATP-competitive PKC inhibitor (IC<sub>50</sub> = 15 nM, rat brain PKC) inhibits PKC&alpha, &betaI, &betaII, &gamma, and &epsilon with IC<sub>50</sub> values of 8, 8, 14, 13, and 39 nM, respectively also inhibits